Unicycive Therapeutics Inc XNAS: UNCY

Unicycive Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Unicycive Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Unicycive Therapeutics Inc
Rating: 1.53933325
Author: Trendlyne DVM scores

Download real time

0.59 0.04 (7.27%)

63.12% Fall from 52W High

1.4M XNAS Volume

XNAS 03 Apr, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Unicycive Therapeutics Inc is on 07 Apr 2025 for the purpose of 24th Annual Needham Virtual Healthcare Conference See details

Not Eligible

-

Expensive Valuation

7.3 / 100

Technically Neutral

54.2 / 100

6

1Yr Price target upside is 959%

6 analysts

Unicycive Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Unicycive Therapeutics Inc FAQ

How is Unicycive Therapeutics Inc today?

Unicycive Therapeutics Inc today is trading in the green, and is up by 7.27% at 0.59.

How has Unicycive Therapeutics Inc performed historically?

Unicycive Therapeutics Inc is currently trading up 7.27% on an intraday basis. In the past week the stock fell -4.84%. stock has been down -25.32% in the past quarter and fell -57.25% in the past year. You can view this in the overview section.